Boston Scientific Corp (BSX)vsXtant Medical Holdings Inc (XTNT)
BSX
Boston Scientific Corp
$69.78
+2.39%
HEALTHCARE · Cap: $101.28B
XTNT
Xtant Medical Holdings Inc
$0.56
+0.55%
HEALTHCARE · Cap: $81.52M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 14984% more annual revenue ($20.07B vs $133.08M). BSX leads profitability with a 14.4% profit margin vs 1.3%. BSX appears more attractively valued with a PEG of 0.75. BSX earns a higher WallStSmart Score of 63/100 (C+).
BSX
Buy63
out of 100
Grade: C+
XTNT
Hold50
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.2%
Fair Value
$70.62
Current Price
$69.78
$0.84 discount
Margin of Safety
-744.3%
Fair Value
$0.07
Current Price
$0.56
$0.49 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Reasonable price relative to book value
19.0% revenue growth
Areas to Watch
Premium valuation, high expectations priced in
Expensive relative to growth rate
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 3.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : XTNT
The strongest argument for XTNT centers on Price/Book, Revenue Growth. Revenue growth of 19.0% demonstrates continued momentum.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : XTNT
The primary concerns for XTNT are PEG Ratio, EPS Growth, Market Cap. A P/E of 58.2x leaves little room for execution misses. Thin 1.3% margins leave little buffer for downturns.
Key Dynamics to Monitor
BSX carries more volatility with a beta of 0.70 — expect wider price swings.
XTNT is growing revenue faster at 19.0% — sustainability is the question.
BSX generates stronger free cash flow (1.0B), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BSX scores higher overall (63/100 vs 50/100) and 15.9% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Xtant Medical Holdings Inc
HEALTHCARE · MEDICAL DEVICES · USA
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company is headquartered in Belgrade, Montana.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?